retatrutide trials weight loss Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide, a new weight loss

I've learned so much about this cool little molecule, and I hope you feel like you know a bit more about it too today

How widespread is GLP-1 usage in the U.S

Purity testing measures one thing

Conclusions In sum, the study found undetectable levels of semaglutide in breast milk at an LLOQ of 5.7 ng/ml

Hepatic Steatosis : Recently, a sub-study of the phase 3 clinical trial SURPASS-3 showed that, among patients receiving metformin and/or SGLT2 inhibitors, the addition of tirzepatide (10 or 15 mg) as compared to insulin degludec was able to significantly reduce hepatic fat content (evaluated by magnetic resonance) after 52 weeks of treatment